Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.
Amgen stock last closed at $290.29, up 2.13% from the previous day, and has decreased 8.89% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.05 percentage points. Amgen stock is currently +14.6% from its 52-week low of $253.30, and -14.41% from its 52-week high of $339.17.
At the moment, there are 538.36M shares of AMGN outstanding. The market cap of AMGN is $156.28B. In the past 24 hours, 1.93M AMGN shares were traded.
How to Buy Amgen Stock
Wondering how to invest in Amgen stock? Here's how.
Choose where to buy Amgen stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Amgen stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Choose your method of payment and add your info.
Research Amgen stock: The Amgen ticker symbol is AMGN. Is Amgen stock a good investment? Should you buy shares of AMGN? How do AMGN's underlying business fundamentals look? Do top analysts think Amgen is a good buy? Why has AMGN's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if AMGN is a good stock to buy).
Execute your AMGN purchase: Decide if you will purchase AMGN shares at the current market price or use a limit order to purchase AMGN stock at a given price.
Get updates on your AMGN position: Create a watchlist to keep track of your new investment in Amgen shares.
Step 1: Choose where to buy Amgen stock
You will need an online brokerage account to access the NASDAQ market and buy AMGN shares.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can invest in AMGN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Amgen stock
After you have decided on the best place to buy Amgen stock, it's critical to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Amgen Metrics
AMGN Price
$290.29
1w %
2.86%
1y %
-8.89%
5y %
22%
P/E
23.56x
P/B
21.04x
P/S
4.47x
PEG
1.08x
Revenue
$34.92B
Earnings
$6.62B
Fore. Rev. Growth
2.07%
Fore. Earn. Growth
21.82%
Market Cap
$156.28B
Next Earnings
N/A
Next Dividend
Sep 12, 2025
AMGN Due Diligence Score
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
AMGN's operating cash flow of $12.01B allows it to safely service it's debt of $56.20B.
There are more short-term assets than short-term liabilities on the AMGN balance sheet.
AMGN profit margin has gone up from 10.1% to 19% in the past year.
Negative Health Checks:
AMGN has a relatively high debt to equity ratio of 10.83.
Total AMGN debt is higher than 5 years ago, relative to shareholder equity.
There are more long-term liabilities than short-term assets on the AMGN balance sheet.
AMGN earnings of $10.36B is not enough to cover its interest payments.
Do analysts think it's a good time to buy AMGN stock
Out of 10 sell side analysts who give ratings on AMGN, the consensus analyst rating on Amgen is a Hold
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest AMGN Analyst Upgrades/Downgrades
Carter Gould, a top 15% analyst from Cantor Fitzgerald reiterates AMGN with a hold rating and maintains their AMGN price target from $305.00 to $305.00, on Jun 24, 2025.
Vamil Divan, a top 4% analyst from Guggenheim assumes AMGN with a hold rating and announces their AMGN price target of $288.00, on May 20, 2025.
Salim Syed, a bottom 7% analyst from Mizuho maintains AMGN with a hold rating and raises their AMGN price target from $235.00 to $280.00, on May 7, 2025.
Gregory Renza, a top 5% analyst from RBC Capital maintains AMGN with a buy rating and lowers their AMGN price target from $324.00 to $320.00, on May 2, 2025.
Colin Bristow, a bottom 5% analyst from UBS maintains AMGN with a hold rating and raises their AMGN price target from $315.00 to $319.00, on Apr 14, 2025.
You can dig deeper into what analysts are projecting on the Amgen stock forecast page.
AMGN Momentum
SMA10
290.58
SMA20
296.49
SMA50
293.09
SMA100
288.8
SMA200
289.84
MACD
-1.36
MACD Signal
-0.56
MACD Histogram
-0.79
RSI
53.09
Stochastic %K
41.83
Stochastic %D
27.91
StochRSI %K
48.43
StochRSI %D
28.67
AMGN Growth Numbers
Last year, AMGN earnings were $6.62B. Over the last five year, AMGN's earnings have grown by -0.02% per year. This was slower than the Drug Manufacturers - General industry average of 5.81%.
Last year, AMGN revenue was $34.92B. During the past 5 year, AMGN's revenue has grown by 7.52% per year. This was slower than the Drug Manufacturers - General industry average of 9.75%.
Amgen pays a dividend of 3.19%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.06%. If you owned $1,000 of AMGN stock, you would have been paid $31.90 in the past year.
Amgen dividend payments have consistently grown over the past decade and have remained stable.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your AMGN purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Click the Open Trade button and your broker will execute the order.
If you want additional assistance investing in stocks on eToro, watch the how to video below:
As of Aug 14, 2025, it costs $290.29 to buy one share of Amgen stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.344 shares of AMGN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.